Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer models.
about
MicroRNA Regulation of Human Breast Cancer Stem CellsMicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerCancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistanceEpigenetic determinants of metastasisCircular RNA participates in the carcinogenesis and the malignant behavior of cancer.MiR-300 regulate the malignancy of breast cancer by targeting p53.p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.The relevance of EMT in breast cancer metastasis: Correlation or causality?miR-138-Mediated Regulation of KINDLIN-2 Expression Modulates Sensitivity to Chemotherapeutics.MiR-138: A promising therapeutic target for cancer.MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.Primary breast cancer induces pulmonary vascular hyperpermeability and promotes metastasis via the VEGF-PKC pathway.miR-138-1* regulates aflatoxin B1-induced malignant transformation of BEAS-2B cells by targeting PDK1.Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A.miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway.
P2860
Q26771792-554DBAB6-B96C-4680-A69C-C75064D3FA3FQ26801108-CA0A0DA0-B58C-4505-BC97-BDB75120851EQ26829987-A4B760CF-9A7B-45B8-AA9E-29A147C965D3Q28079377-064F63CB-FC90-4F88-875A-8B7AD4B3613AQ33739727-75829C07-BAD6-424C-A088-69820130FB12Q35870648-39B39FC0-F363-4E6C-9F89-1AC6A2A92B5BQ36507886-976BAD6D-851D-421B-A323-C902AA599FAFQ38483125-0AAF4D05-F4EA-45C2-9DD5-61225F6DF22FQ38512093-32A1DE85-20CE-417D-AFF0-7ACA95AC26E2Q38734800-22075CB6-8784-4511-ABFD-C1FDED0095D2Q38750019-627FB9FE-6796-4AF3-86E2-FD6732725DDAQ38855665-AB1AC42F-58DE-4029-AA51-922E4A18C10BQ38862911-BA79783C-76FC-4C9A-8120-12383AB72C51Q41145069-E455B3F2-65F8-43AA-B592-4C89D3B1D73EQ46142063-7F627AC3-077C-417F-B493-6A20A2924532
P2860
Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer models.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Differentiation and loss of ma ...... -derived breast cancer models.
@ast
Differentiation and loss of ma ...... -derived breast cancer models.
@en
type
label
Differentiation and loss of ma ...... -derived breast cancer models.
@ast
Differentiation and loss of ma ...... -derived breast cancer models.
@en
prefLabel
Differentiation and loss of ma ...... -derived breast cancer models.
@ast
Differentiation and loss of ma ...... -derived breast cancer models.
@en
P2093
P2860
P50
P1433
P1476
Differentiation and loss of ma ...... t-derived breast cancer models
@en
P2093
Chika Nwachukwu
Huiping Liu
Jessica Bockhorn
Maria J Gomez-Vega
Meng Shang
Simo Huang
Ya-Fang Chang
P2860
P304
P356
10.1158/0008-5472.CAN-14-1188
P407
P577
2014-10-22T00:00:00Z